New Zealand markets closed

Bionano Genomics, Inc. (BNGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.15-0.05 (-0.96%)
At close: 4:00PM EDT
5.15 0.00 (0.00%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
13,209
8,503
10,130
12,001
9,505
Cost of revenue
8,813
5,730
6,768
8,711
6,031
Gross profit
4,396
2,773
3,361
3,289
3,475
Operating expenses
Research development
11,946
10,256
9,081
9,484
12,009
Selling general and administrative
41,444
31,068
20,155
14,220
14,080
Total operating expenses
53,390
41,324
29,236
23,704
26,089
Operating income or loss
-48,994
-38,551
-25,875
-20,415
-22,614
Interest expense
1,945
2,519
2,286
1,381
590.927
Total other income/expenses net
-281.943
-6.943
-1,633
3,315
-141.588
Income before tax
-51,221
-41,077
-29,794
-18,481
-23,347
Income tax expense
34.193
29.193
21.048
15.511
18.552
Income from continuing operations
-51,255
-41,106
-29,815
-18,496
-23,365
Net income
-51,255
-41,106
-29,815
-18,496
-23,365
Net income available to common shareholders
-51,255
-41,106
-29,815
-18,496
-23,365
Basic EPS
-
-0.22
-0.87
-1.84
-8.65
Diluted EPS
-
-0.22
-0.87
-1.84
-8.65
Basic average shares
-
189,953
34,274
10,055
2,701
Diluted average shares
-
189,953
34,274
10,055
2,701
EBITDA
-
-37,079
-26,380
-15,779
-21,252